Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
作者信息
Tjon Pian Gi Robin E A, Dietz Andreas, Djukic Vojko, Eckel Hans E, Friedrich Gerhard, Golusinski Wojciech, Hantzakos Anastasios, Lawson George, Remacle Marc, Rihkanen Heikki, Dikkers Frederik G
出版信息
Eur Arch Otorhinolaryngol. 2012 Feb;269(2):361-2. doi: 10.1007/s00405-011-1804-7. Epub 2011 Oct 22.
Abstract
摘要
相似文献
1
Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).复发性呼吸道乳头状瘤病的治疗及西多福韦（Vistide®）超说明书用药后的不良反应
Eur Arch Otorhinolaryngol. 2012 Feb;269(2):361-2. doi: 10.1007/s00405-011-1804-7. Epub 2011 Oct 22.
2
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.复发性呼吸道乳头瘤病患者瘤内使用西多福韦的安全性：635 例 RRP 患者的国际回顾性研究。
Eur Arch Otorhinolaryngol. 2013 May;270(5):1679-87. doi: 10.1007/s00405-013-2358-7. Epub 2013 Feb 3.
3
Current use of intralesional cidofovir for recurrent respiratory papillomatosis.目前应用病灶内西多福韦治疗复发性呼吸道乳头瘤病。
Laryngoscope. 2013 Mar;123(3):705-12. doi: 10.1002/lary.23673. Epub 2012 Oct 15.
4
Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.与使用西多福韦治疗良性人乳头瘤病毒相关疾病相关的潜在风险因素。
Antivir Ther. 2009;14(7):939-52. doi: 10.3851/IMP1421.
5
Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis.吸入西多福韦作为复发性呼吸道乳头瘤病的辅助治疗。
Otolaryngol Head Neck Surg. 2011 Apr;144(4):639-41. doi: 10.1177/0194599810395353. Epub 2011 Feb 4.
6
Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.西多福韦在复发性呼吸道乳头状瘤病的人乳头瘤病毒（HPV）患者中的应用。
Eur Arch Otorhinolaryngol. 2014 Nov;271(11):2983-90. doi: 10.1007/s00405-014-3055-x. Epub 2014 Apr 23.
7
Letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".致编辑的信：关于“病灶内西多福韦给药方案治疗复发性呼吸道乳头状瘤病的系统评价”
Int J Pediatr Otorhinolaryngol. 2013 Oct;77(10):1789. doi: 10.1016/j.ijporl.2013.08.016. Epub 2013 Aug 27.
8
Response to Dikkers letter to the editor regarding "systematic review of intralesional cidofovir dosing regimens in the treatment of recurrent respiratory papillomatosis".对迪克斯致编辑的信的回复，该信涉及“关于病灶内西多福韦给药方案治疗复发性呼吸道乳头状瘤病的系统评价”
Int J Pediatr Otorhinolaryngol. 2013 Oct;77(10):1789. doi: 10.1016/j.ijporl.2013.08.017. Epub 2013 Aug 27.
9
Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature.西多福韦治疗复发性呼吸道乳头状瘤病：文献综述
Pharmacotherapy. 2005 Jul;25(7):977-89. doi: 10.1592/phco.2005.25.7.977.
10
Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.西多福韦皮损内治疗复发性呼吸道乳头瘤病的疗效。
Eur Arch Otorhinolaryngol. 2011 Sep;268(9):1305-11. doi: 10.1007/s00405-011-1599-6. Epub 2011 Apr 26.
引用本文的文献
1
Recurrent respiratory papillomatosis: role of bevacizumab and HPV vaccination. A literature review with case presentations.复发性呼吸道乳头状瘤病：贝伐单抗和人乳头瘤病毒疫苗接种的作用。附病例报告的文献综述。
Radiol Oncol. 2025 Feb 27;59(1):23-30. doi: 10.2478/raon-2025-0010. eCollection 2025 Mar 1.
2
Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.复发性喉乳头状瘤：多模态治疗策略。文献回顾和多中心回顾性研究。
Acta Otorhinolaryngol Ital. 2023 Apr;43(Suppl. 1):S111-S122. doi: 10.14639/0392-100X-suppl.1-43-2023-14.
3
Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects.药物化学中的膦酸盐和膦酸盐前药：过去的成功与未来的前景
Front Chem. 2022 May 20;10:889737. doi: 10.3389/fchem.2022.889737. eCollection 2022.
4
European Laryngological Society position paper on laryngeal dysplasia Part II: diagnosis, treatment, and follow-up.欧洲喉科学会关于喉发育异常的立场文件 第二部分：诊断、治疗及随访
Eur Arch Otorhinolaryngol. 2021 Jun;278(6):1723-1732. doi: 10.1007/s00405-020-06406-9. Epub 2020 Oct 14.
5
Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.人乳头瘤病毒引起的复发性呼吸道乳头状瘤病：文献综述及西多福韦应用的最新进展
Acta Otorhinolaryngol Ital. 2014 Dec;34(6):375-81.
6
Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.西多福韦在复发性呼吸道乳头状瘤病的人乳头瘤病毒（HPV）患者中的应用。
Eur Arch Otorhinolaryngol. 2014 Nov;271(11):2983-90. doi: 10.1007/s00405-014-3055-x. Epub 2014 Apr 23.
7
Diagnostic and therapeutic pitfalls in benign vocal fold diseases.良性声带疾病的诊断与治疗误区
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2013 Dec 13;12:Doc01. doi: 10.3205/cto000093.
8
Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis.四价人乳头瘤病毒（6/11/16/18 型）疫苗在复发性呼吸道乳头瘤病患者中的临床疗效。
Eur Arch Otorhinolaryngol. 2014 May;271(5):1135-42. doi: 10.1007/s00405-013-2755-y.
9
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.复发性呼吸道乳头瘤病患者瘤内使用西多福韦的安全性：635 例 RRP 患者的国际回顾性研究。
Eur Arch Otorhinolaryngol. 2013 May;270(5):1679-87. doi: 10.1007/s00405-013-2358-7. Epub 2013 Feb 3.
10
Therapy of human papillomavirus-related disease.人乳头瘤病毒相关性疾病的治疗。
Vaccine. 2012 Nov 20;30 Suppl 5(0 5):F71-82. doi: 10.1016/j.vaccine.2012.05.091.
本文引用的文献
1
Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.西多福韦皮损内治疗复发性呼吸道乳头瘤病的疗效。
Eur Arch Otorhinolaryngol. 2011 Sep;268(9):1305-11. doi: 10.1007/s00405-011-1599-6. Epub 2011 Apr 26.
2
Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.西多福韦治疗复发性呼吸道乳头状瘤病的疗效：一项随机、双盲、安慰剂对照研究。
Ann Otol Rhinol Laryngol. 2008 Jul;117(7):477-83. doi: 10.1177/000348940811700702.
3
Adult intralesional cidofovir therapy for laryngeal papilloma: a 10-year perspective.成人喉乳头状瘤病灶内西多福韦治疗：十年回顾
Arch Otolaryngol Head Neck Surg. 2008 May;134(5):497-500. doi: 10.1001/archotol.134.5.497.
4
Specific therapies for human papilloma virus infections.人乳头瘤病毒感染的特异性疗法。
Curr Opin Infect Dis. 1998 Dec;11(6):733-7. doi: 10.1097/00001432-199812000-00014.
5
Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir--a prospective study.显微手术联合病灶内注射西多福韦治疗复发性呼吸道乳头状瘤病——一项前瞻性研究
Eur Arch Otorhinolaryngol. 2006 May;263(5):440-3. doi: 10.1007/s00405-005-1013-3. Epub 2005 Nov 22.
6
Intralesional cidofovir and surgical excision for laryngeal papillomatosis.喉乳头状瘤病的病灶内注射西多福韦及手术切除
Laryngoscope. 2003 Dec;113(12):2174-81. doi: 10.1097/00005537-200312000-00024.
7
Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir.使用病灶内西多福韦治疗小儿复发性呼吸道乳头状瘤病的长期随访
Laryngoscope. 2003 Sep;113(9):1583-7. doi: 10.1097/00005537-200309000-00032.
8
Intralesional cidofovir therapy for laryngeal papilloma in an adult cohort.成人队列中喉乳头状瘤的病灶内西多福韦治疗
Laryngoscope. 2002 Apr;112(4):696-9. doi: 10.1097/00005537-200204000-00019.
9
Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.抗病毒核苷酸类似物西多福韦和阿德福韦的临床药代动力学
Clin Pharmacokinet. 1999 Feb;36(2):127-43. doi: 10.2165/00003088-199936020-00004.
Zotero 插件